Format

Send to

Choose Destination
Recenti Prog Med. 2015 Dec;106(12):653e-6e. doi: 10.1701/2094.22666.

[Efficacy and safety of antivascular drugs after anti-EFGR: aflibercept after cetuximab, a clinical case].

[Article in Italian]

Abstract

We describe a case of a man affected by colon adenocarcinoma with metachronous nodes and liver metastases (resected), exposed to first line therapy with FOLFOX-cetuximab. After disease progression, a second line based on FOLFIRI-aflibercept was started achieving an initial partial response followed by a long-lasting disease stability with a good tolerability.

PMID:
26780078
DOI:
10.1701/2094.22666
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Il Pensiero Scientifico Editore
Loading ...
Support Center